Lilly, Incyte rheumatoid arthritis drug succeeds. ~ SEAHORSEGEOCITY LINEAGE

NEWS ENTERTAINMENT LIFE STYLE SPORTS TRAVELS REAL ESTATE.

SEAHORSEGEOCITY LINEAGE

NEWS ENTERTAINMENT LIFE STYLE SPORTS TRAVELS REAL ESTATE.



Tuesday, September 29, 2015

Lilly, Incyte rheumatoid arthritis drug succeeds.

Eli Lilly and Co and Incyte Corp said a third late-stage study of their experimental rheumatoid arthritis drug met its main goal.
The drug, baricitinib, was more effective than the decades-old treatment methotrexate, after 24 weeks of treatment, in reducing signs and symptoms of the inflammatory disorder, the companies said on Tuesday.

Related Posts:

Contact Us

Name

Email *

Message *

Recent Popular Posts

Seahorsegeocity. Powered by Blogger.

Popular Posts